Literature DB >> 12619931

Functional domains for amelogenin revealed by compound genetic defects.

Michael L Paine1, Wen Luo, Dan-Hong Zhu, Pablo Bringas, Malcolm L Snead.   

Abstract

We have previously used the yeast two-hybrid assay and multiple in vitro methodologies to show that amelogenin undergoes self-assembly involving two domains (A and B). Using transgenic animals, we show that unique enamel phenotypes result from disruptions to either the A- or B-domain, supporting the role of amelogenin in influencing enamel structural organization. By crossbreeding, animals bearing two defective amelogenin gene products have a more extreme enamel phenotype than the sum of the defects evident in the individual parental lines. At the nanoscale level, the forming matrix shows alteration in the size of the amelogenin nanospheres. At the mesoscale level of enamel structural hierarchy, 6-week-old enamel exhibits defects in enamel rod organization caused by perturbed organization of the precursor organic matrix. These studies reflect the critical dependency of amelogenin self-assembly to form a highly organized enamel organic matrix, and that amelogenins engineered to be defective in self-assembly produce compound defects in the structural organization of enamel.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619931     DOI: 10.1359/jbmr.2003.18.3.466

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Molecular evolution of amelogenin in mammals.

Authors:  Sidney Delgado; Marc Girondot; Jean-Yves Sire
Journal:  J Mol Evol       Date:  2005-01       Impact factor: 2.395

2.  Leucine-rich amelogenin peptides regulate mineralization in vitro.

Authors:  E Le Norcy; S-Y Kwak; F B Wiedemann-Bidlack; E Beniash; Y Yamakoshi; J P Simmer; H C Margolis
Journal:  J Dent Res       Date:  2011-06-07       Impact factor: 6.116

3.  Potential role of the amelogenin N-terminus in the regulation of calcium phosphate formation in vitro.

Authors:  E Le Norcy; S-Y Kwak; F B Wiedemann-Bidlack; E Beniash; Y Yamakoshi; J P Simmer; H C Margolis
Journal:  Cells Tissues Organs       Date:  2011-05-13       Impact factor: 2.481

Review 4.  DENTAL ENAMEL FORMATION AND IMPLICATIONS FOR ORAL HEALTH AND DISEASE.

Authors:  Rodrigo S Lacruz; Stefan Habelitz; J Timothy Wright; Michael L Paine
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

5.  Structural adaptation of tooth enamel protein amelogenin in the presence of SDS micelles.

Authors:  Karthik Balakrishna Chandrababu; Kaushik Dutta; Sowmya Bekshe Lokappa; Moise Ndao; John Spencer Evans; Janet Moradian-Oldak
Journal:  Biopolymers       Date:  2014-05       Impact factor: 2.505

6.  The role of amelogenin during enamel-crystallite growth and organization in vivo.

Authors:  J Tim Wright; Yong Li; Cynthia Suggs; Melissa A Kuehl; Ashok B Kulkarni; Carolyn W Gibson
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

7.  Effect of phosphorylation on the interaction of calcium with leucine-rich amelogenin peptide.

Authors:  Elvire Le Norcy; Seo-Young Kwak; Marc Allaire; Peter Fratzl; Yasuo Yamakoshi; James P Simmer; Henry C Margolis
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

8.  Cloning of rat amelotin and localization of the protein to the basal lamina of maturation stage ameloblasts and junctional epithelium.

Authors:  Pierre Moffatt; Charles E Smith; René St-Arnaud; Darrin Simmons; J Timothy Wright; Antonio Nanci
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

9.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

10.  Synergistic roles of amelogenin and ameloblastin.

Authors:  J Hatakeyama; S Fukumoto; T Nakamura; N Haruyama; S Suzuki; Y Hatakeyama; L Shum; C W Gibson; Y Yamada; A B Kulkarni
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.